# David Stoffel

> David Stoffel is the Chief Business Officer of RapidAI, the clinical-AI company whose stroke-imaging algorithms helped rewrite the rules of how strokes get treated. A medical doctor who chose boardrooms over bedsides, he has spent more than two decades turning ambitious medical technologies into standards of care - from the da Vinci surgical robot at Intuitive Surgical to mobile cardiac telemetry at iRhythm and point-of-care EEG at Ceribell. At RapidAI he runs the commercial engine: marketing, clinical affairs, education, customer success, corporate development, and finance.

- **Role:** Chief Business Officer at RapidAI
- **Organizations:** RapidAI, Ceribell, iRhythm Technologies, Intuitive Surgical, Radius Ventures, Credit Suisse First Boston
- **Nationality:** American
- **Education:** BA in Economics (and Biology), Stanford University, MD, University of Chicago Pritzker School of Medicine, MBA, Finance and Marketing, University of Chicago Booth School of Business
- **Known for:** Helped establish the da Vinci surgical robotic system as a new standard of care at Intuitive Surgical, Helped launch and lead the Mobile Cardiac Telemetry business at iRhythm Technologies, Served as Chief Business Officer at Ceribell, scaling point-of-care EEG

## Career timeline

- **2001** — Associate in the Healthcare division at Credit Suisse First Boston
- **2003** — Partner at Radius Ventures, a healthcare venture capital firm
- **2008** — Joins Intuitive Surgical, eventually leading marketing and business development for the da Vinci system
- **2019** — VP of Mobile Cardiac Telemetry at iRhythm Technologies
- **2021** — Chief Business Officer at Ceribell, maker of a point-of-care EEG solution
- **2023** — Becomes Chief Business Officer at RapidAI

## Achievements

- Helped establish the da Vinci surgical robotic system as a new standard of care at Intuitive Surgical
- Helped launch and lead the Mobile Cardiac Telemetry business at iRhythm Technologies
- Served as Chief Business Officer at Ceribell, scaling point-of-care EEG
- Leads commercial, clinical, and operational teams at RapidAI, whose algorithms underpinned the DAWN and DEFUSE stroke trials published in the New England Journal of Medicine
- Featured guest on the Becker's Healthcare Podcast discussing AI's impact on patient care

## Latest updates

- **2024-01** — Appeared on the Becker's Healthcare Podcast episode 'Beyond Billion Pixels: AI's Impact on Patient Care.'
- **2024-12** — Featured by RapidAI at RSNA24 as Chief Business Officer.
- **2025-02** — Interviewed at the International Stroke Conference (ISC25) about AI in stroke care.

## Links

- Website: https://www.rapidai.com
- LinkedIn: http://www.linkedin.com/in/david-stoffel-b624ab10
- YouTube: https://www.youtube.com/watch?v=NHlmzLpCPek

---

Profile page: https://yespress.io/david-stoffel
Published by YesPress — https://yespress.io
Last updated: 2026-06-13